Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies

Respiratory Care

Volumn 58, Issue 7, 2013, Pages 1220-1225

  Restrepo, Marcos I ^a,c   Peterson, Janet ^b   Fernandez, Juan F ^a   Qin, Zhihai ^b   Fisher, Alan C ^b   Nicholson, Susan C ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Critical care; Early onset; ICU; Late onset; Mechanical ventilation; Microbiology; Outcome and process assessment; Ventilator associated pneumonia

Indexed keywords

DORIPENEM; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER BAUMANNII; ADULT; AGE DISTRIBUTION; APACHE; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE PREDISPOSITION; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; ONSET AGE; OUTCOME ASSESSMENT; PATHOGENESIS; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VENTILATOR ASSOCIATED PNEUMONIA;

CRITICAL CARE; EARLY ONSET; ICU; LATE ONSET; MECHANICAL VENTILATION; MICROBIOLOGY; OUTCOME AND PROCESS ASSESSMENT; VENTILATOR-ASSOCIATED PNEUMONIA;

ACINETOBACTER BAUMANNII; ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; APACHE; BACTEREMIA; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PNEUMONIA, VENTILATOR-ASSOCIATED; PREVALENCE; PSEUDOMONAS AERUGINOSA; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SEX FACTORS; STAPHYLOCOCCUS AUREUS; STATISTICS AS TOPIC; TIME FACTORS;

EID: 84879369871     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02173     Document Type: Article

References (24)

1. Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986;133(5):792-796.
2. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53(RR-3):1-36.
3. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165(7):867-903.
4. Collard HR, Saint S, Matthay MA. Prevention of ventilatorassociated pneumonia: an evidence-based systematic review. Ann Intern Med 2003;138(6):494-501.
5. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128(6):3854-3862.
6. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kolleg MH; VAP Outcomes Scientific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122(6):2115-2121.
7. Kappstein I, Schulgen G, Beyer U, Geiger K, Schumacher M, Daschner FD. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992;11(6):504-508.
8. Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003;31(5):1312-1317.
9. Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilatorassociated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol 2012;33(3):250-256.
10. Dudeck MA, Horan TC, Peterson KD, Allen Bridson K, Morrell G, Pollock DA, Edwards JR. National Healthcare Safety Network (NHSN) Report, data summary from 2010, device-associated module. Am J Infect Control 2011;39(10):798-816.
11. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171(4):388-416.
12. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157(2):531-539.
13. Prod'hom G, Leuenberger P, Koerfer J, Blum A, Chiolero R, Schaller MD, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med 1994; 120(8):653-662.
14. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996;153(5):1711-1725.
15. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999;160(2):608-613.
16. Craven DE. Epidemiology of ventilator-associated pneumonia. Chest 2000;117(4 Suppl 2):186S-187S.
17. Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997;111(3):676-685.
18. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115(2):462-474.
19. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122(1): 262-268.
20. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36(1):53-59.
21. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118(1):146-155.
22. Réa-Neto A, Niederman M, Lobo SM, Schroeder E, Lee M, Kaniga K, et al. Efficacy and safety of doripenem versus piperacillin/ tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study. Curr Med Res Opin 2008;24(7):2113-2126.
23. Chastre J, Wunderink R, Prokocimer P, Lee M, Kaniga K, Friedland I. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Crit Care Med 2008;36(4):1089-1096.
24. Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003;31(3): 676-682.